By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Cellectar Biosciences (Formerly Known As Novelos Therapeutics, Inc.)  

3301 Agriculture Drive

Madison  Wisconsin  53716  U.S.A.
Phone: 608-441-8120 Fax: 608-441-8120



Drug Discovery

Company News
Cellectar Biosciences  (NVLT) Chief Scientific Officer Receives International Recognition For Pioneering Research 11/20/2015 8:00:58 AM
Cellectar Biosciences  (NVLT) Announces Third Quarter Financial Results 11/13/2015 10:00:05 AM
Cellectar Biosciences  (NVLT) Converts Patent Application For Phospholipid-Ether Analogs As Cancer Targeting Drug Vehicles 11/10/2015 7:51:57 AM
Cellectar Biosciences  (NVLT) To Host Conference Call On November 12th To Discuss Third Quarter Financial Results And Provide Clinical Development Program Update 11/5/2015 10:16:32 AM
Cellectar Biosciences  (NVLT) Provides Phospholipid Drug Conjugate (PDC) Platform Development Update 11/2/2015 7:43:12 AM
Cellectar Biosciences  (NVLT) To Present At The 2015 BIO Investor Forum 10/16/2015 8:07:54 AM
Cellectar Biosciences  (NVLT) Closes On $3.3 Million Financing 10/2/2015 7:29:24 AM
Cellectar Biosciences  (NVLT) Awarded $2.3 Million National Cancer Institute Fast-Track SBIR Grant To Advance Phospholipid Drug Conjugate (PDC) Delivery Platform 10/1/2015 7:29:15 AM
Cellectar Biosciences  (NVLT) Announces Pricing Of $3.3 Million Financing 9/28/2015 7:41:34 AM
Cellectar Biosciences  (NVLT) To Present At The Ladenburg Thalmann 2015 Healthcare Conference 9/25/2015 8:10:40 AM